Clinical trial Recruiting at 67 sites Observational Ages 18 and up

Global registry for patients with type 2 diabetes and related conditions

Official title: Real-world Multinational Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases

Run by AstraZeneca · NCT03549754 · Data updated 2026-11-12

This study is collecting information from doctors around the world about patients with type 2 diabetes and related health issues to better understand how these conditions are managed and treated.

More Hypertension trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment35000 (estimated)
SponsorAstraZeneca
Industry-sponsored
Locations76 sites (Fortaleza, Ceará and 75 other locations)
StatusRecruiting
StartedFebruary 17, 2018
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedSeptember 9, 2026
Trial IDNCT03549754 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are adults aged 18 and older diagnosed with type 2 diabetes, hypertension, heart failure, and/or chronic kidney disease.

Probably not a fit

Patients with life-threatening co-morbidities and a life expectancy of less than one year may not benefit from participation in this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to collect real-world data on patient characteristics, disease management, healthcare utilization, and outcomes for individuals with type 2 diabetes, hypertension, heart failure, and chronic kidney disease. It will utilize a cloud-based electronic case report form (eCRF) for both prospective and retrospective data collection, making it accessible to investigators and a Scientific Committee. The registry is open to physicians worldwide who manage these conditions, facilitating a comprehensive understanding of patient care in clinical practice.

Why it matters

Potential benefit: If successful, this registry could enhance the understanding of disease management and improve healthcare outcomes for patients with these chronic conditions.

How similar studies have gone: Other observational registries have successfully provided valuable insights into chronic disease management, indicating that this approach is both tested and beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Being 18 years or older
2. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
3. Providing written informed consent to participate in the registry

Exclusion Criteria:

1. Having a life-threatening co-morbidity with life expectancy below 1 year
2. Participating in an interventional trial requiring informed consent

Where it's running

  • Research Site
    Fortaleza, Ceará, Brazil
    Recruiting
  • Research Site
    Colatina, Espírito Santo (ES), Brazil
    Recruiting
  • Research Site
    Salvador, Estado de Bahia, Brazil
    Recruiting
  • Research Site
    Brasília, Federal District, Brazil
    Recruiting
  • Research Site
    Poços de Caldas, Minas Gerais, Brazil
    Recruiting
  • Research Site
    Campina Grande do Sul, Paraná, Brazil
    Recruiting
Show 44 more locations
  • Research Site
    Curitiba, Paraná, Brazil
    Recruiting
  • Research Site
    Teresina, Piauí (PI), Brazil
    Recruiting
  • Research Site
    Santa Cruz do Sul, Rio Grande Do Sul (RS), Brazil
    Recruiting
  • Research Site
    Goiânia, State of Goias, Brazil
    Recruiting
  • Research Site
    Joinville, State of Santa Catarina, Brazil
    Recruiting
  • Research Site
    Bragança Paulista, São Paulo, Brazil
    Recruiting
  • Research Site
    São Caetano do Sul, São Paulo, Brazil
    Recruiting
  • Research Site
    São Paulo, Brazil
    Recruiting
  • Research Site
    São Paulo, Brazil
    Recruiting
  • Research Site
    Providencia, Santiago Metropolitan, Chile
    Recruiting
  • Research Site
    San José, Costa Rica
    Recruiting
  • Research Site
    Abidjan, Côte d’Ivoire
    Recruiting
  • Research Site
    Alexandria, Egypt
    Recruiting
  • Research Site
    Cairo, Egypt
    Recruiting
  • Research Site
    Giza, Egypt
    Recruiting
  • Research Site
    Tbilisi, Georgia
    Recruiting
  • Research Site
    Kumasi, Ghana
    Recruiting
  • Research Site
    Wan Chai, Hong Kong
    Recruiting
  • Research Site
    Ahmedabad, India
    Recruiting
  • Research Site
    Kolkata, India
    Recruiting
  • Research Site
    Mumbai, India
    Recruiting
  • Research Site
    Sulaymaniyah, Iraq
    Recruiting
  • Research Site
    Aktobe, Kazakhstan
    Recruiting
  • Research Site
    Almaty, Kazakhstan
    Recruiting
  • Research Site
    Almaty, Kazakhstan
    Recruiting
  • Research Site
    Almaty, Kazakhstan
    Recruiting
  • Research Site
    Almaty, Kazakhstan
    Recruiting
  • Research Site
    Nairobi, Kenya
    Recruiting
  • Research Site
    Kuala Lumpur, Malaysia
    Recruiting
  • Research Site
    León, Guanajuato, Mexico
    Recruiting
  • Research Site
    Iztapalapa, Mexico
    Recruiting
  • Research Site
    Mexico City, Mexico
    Recruiting
  • Research Site
    Mexico City, Mexico
    Recruiting
  • Research Site
    México, Mexico
    Recruiting
  • Research Site
    Enugu, Nigeria
    Recruiting
  • Research Site
    Gwagwalada, Nigeria
    Recruiting
  • Research Site
    Kano, Nigeria
    Recruiting
  • Research Site
    Cebu City, Philippines
    Recruiting
  • Research Site
    Florida, South Africa
    Recruiting
  • Research Site
    Parow, South Africa
    Recruiting
  • Research Site
    Umhlanga, South Africa
    Recruiting
  • Research Site
    Umhlanga, South Africa
    Recruiting
  • Research Site
    Changhua, Taiwan
    Recruiting
  • Research Site
    Kaohsiung City, Taiwan
    Recruiting

+26 more sites. See ClinicalTrials.gov for the full list.

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.